Physician

Clara Chan, M.D.

According to 2025 Medicare claims, Clara Chan, M.D. (NPI: 1952338592) practices hematology/oncology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from Prince Georges, MD. This provider's primary affiliated billing organization is CLARA S.P. CHAN, MD, PC (NPI: 1144557240) and primary practice location at 20902-5276.

Chan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 138 traditional Medicare patients, billed 49,834 HCPCS/CPT codes, and received $1,183,482 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 97 prescription claims across 19 beneficiaries totaling $294,035 in drug costs, led by Brukinsa (Zanubrutinib). Open Payments data shows 32 records totaling $1,135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $145,469 and ending at $294,035. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$592K$1.2M2015 Medicare payment: $922,518 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,029,918 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,063,227 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $969,902 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $985,105 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $918,262 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $725,024 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $659,860 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $681,021 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,183,482 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201516981,973$922,518
201619085,781$1,029,918
201719686,065$1,063,227
201817576,550$969,902
201917773,908$985,105
202014070,462$918,262
202117258,121$725,024
202215543,049$659,860
202314339,425$681,021
202413849,834$1,183,482

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$267K$535K2015 Drug cost: $145,469 (USD; Tot_Drug_Cst)2016 Drug cost: $162,584 (USD; Tot_Drug_Cst)2017 Drug cost: $534,871 (USD; Tot_Drug_Cst)2018 Drug cost: $188,757 (USD; Tot_Drug_Cst)2019 Drug cost: $261,794 (USD; Tot_Drug_Cst)2020 Drug cost: $176,302 (USD; Tot_Drug_Cst)2021 Drug cost: $394,932 (USD; Tot_Drug_Cst)2022 Drug cost: $229,256 (USD; Tot_Drug_Cst)2023 Drug cost: $184,895 (USD; Tot_Drug_Cst)2024 Drug cost: $294,035 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151371$145,469
20161678$162,584
201719131$534,871
201819114$188,757
20191769$261,794
20201665$176,302
20211794$394,932
20221584$229,256
20231571$184,895
20241997$294,035

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more1616$147
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more133472$108
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle1544$66
96372Injection of drug or substance under skin or into muscle19159$13
J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)1833,900$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BrukinsaZanubrutinib16480$230,538
XareltoRivaroxaban15750$13,865
HydroxyureaHydroxyurea221,440$915

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$1,135AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Clara Chan, M.D.?

Tedicare shows public-source Medicare data for Clara Chan, M.D. (NPI 1952338592), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Clara Chan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Clara Chan, M.D.?

Clara Chan, M.D. is linked to CLARA S.P. CHAN, MD, PC (billing NPI 1144557240) in the available physician profile data.

Does Clara Chan, M.D. have Open Payments data?

Clara Chan, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.